| Network Studies |
|
|
|
|
Each of the following protocols is at a different stage of development. The status of each protocol will be updated on monthly basis.
Please contact
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
for more detailed information. Protocol SEA001 Title: High-Dose versus Standard-Dose Oseltamivir for the Treatment of Severe Influenza and Avian Influenza. A Phase II Double-Blind, Randomized Clinical Trial Protocol SEA002 Title: Pharmacology Study of Oseltamivir and Probenecid in Healthy Asian Subjects Protocol SEA003 Title: Phase 1, Open-Label Study to Evaluate Potential Pharmacokinetic Interactions Between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects Protocol SEA004 Title: Long Term Influenza Prophylaxis with Inhaled Zanamivir or Oral Oseltamivir Protocol SEA005 Title: An Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous Zanamivir Administered Twice Daily for 5 days in Hospitalized Subjects with Confirmed H5N1 Influenza Infection. Protocol SEA 006 Title: Clinical Database of patients with H5N1 infection Protocol SEA007 Title: Host Genetic Susceptibility to Human Influenza A/H5N1 Protocol SEA008 Title: Cardiorespiratory function and radiological changes in lung structure in Indonesian patients who survive highly pathogenic influenza A/H5N1 - a 3 years prospective study |
